FDA.reportPublic FDA data

nirmatrelvir 150 MG Oral Tablet

RxCUI
2587897
RxNorm name
nirmatrelvir 150 MG Oral Tablet
Display name
nirmatrelvir 150 MG Oral Tablet
Full name
nirmatrelvir 150 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PaxlovidNIRMATRELVIR AND RITONAVIRPfizer Laboratories Div Pfizer Inc8a99d6d6-fd9e-45bb-b1bf-48c7f761232a2026-02-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2587897

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8a99d6d6-fd9e-45bb-b1bf-48c7f761232anirmatrelvir 150 MG Oral Tablet [PSN] · nirmatrelvir 150 MG Oral Tablet [SCD]212These highlights do not include all the information needed to use PAXLOVID safely and effectively. See full prescribing information for PAXLOVID. PAXLOVID TM (nirmatrelvir tablets; ritonavir tablets), co-packaged for oral use Initial U.S. Approval: 202320260219